Beijing Centergate Technologies (Holding) Co. Ltd. logo

Beijing Centergate Technologies (Holding) Co. Ltd. (000931)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
4. 19
-0.03
-0.7109%
¥
3.92B Market Cap
49.12 P/E Ratio
0.34% Div Yield
5.63M Volume
0 Eps
¥ 4.22
Previous Close
Add Transaction
Day Range
4.17 4.23
Year Range
3.76 5.73
Want to track 000931 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

000931 closed today lower at ¥4.19, a decrease of -0.7109% from yesterday's close, completing a monthly increase of 1.9465% or ¥0.08. Over the past 12 months, 000931 stock lost -14.1393%.
000931 pays dividends to its shareholders, with the most recent payment made on Jun 12, 2026. The next estimated payment will be in 1 month ago on Jun 12, 2026 for a total of ¥0.02.
The last earnings report, released on May 09, 2025, exceeded the consensus estimates by 0.0209%. On average, the company has surpassed earnings expectations by 0.0172%, based on the last three reports.
Beijing Centergate Technologies (Holding) Co. Ltd. has completed 1 stock splits, with the recent split occurring on Jan 09, 2007.
The company's stock is traded on one exchange.

000931 Chart

Beijing Centergate Technologies (Holding) Co. Ltd. (000931) FAQ

What is the stock price today?

The current price is ¥4.19.

On which exchange is it traded?

Beijing Centergate Technologies (Holding) Co. Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 000931.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.34%.

What is its market cap?

As of today, the market cap is 3.92B.

Has Beijing Centergate Technologies (Holding) Co. Ltd. ever had a stock split?

Beijing Centergate Technologies (Holding) Co. Ltd. had 1 splits and the recent split was on Jan 09, 2007.

Beijing Centergate Technologies (Holding) Co. Ltd. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Zhanjun Hou CEO
XSHE Exchange
CNE000001030 ISIN
CN Country
2,267 Employees
12 Jun 2026 Last Dividend
9 Jan 2007 Last Split
- IPO Date

Overview

Established in 1999 and headquartered in Beijing, China, Beijing Centergate Technologies (holding) Co., Ltd. operates across diverse sectors, including pharmaceutical production and sales, construction, real estate development, and property management. This multifaceted company not only caters to the domestic Chinese market but also has an international presence, showcasing its broad scope of operations and expertise in various industries. Through its efforts, Beijing Centergate Technologies aims to contribute significantly to the fields it operates in, leveraging its rich history and wide-ranging experience.

Products and Services

Huasu West-ground Iodine, Fesser Phenylcycline Hydrochloride, Bosu Fuma Acid Bisolol, Yuanji Beni Flat Hydrochloric Acid, Naloxone Hydrochloride, Five Plus Biochemical, and Aramol Quramado Tablets and Capsules: These pharmaceutical products represent the company's core in drug development and manufacturing. They cater to various medical needs, showcasing the company's commitment to healthcare and medicine.

Mucous Membrane Repair and Oral Health Care Products: This range includes toothpaste, mouthwash, spray, and dental equipment, designed for treating ulcers, burns, mechanical damage, and for postoperative repair. Highlighting the company's venture into personal healthcare, these products emphasize the importance of maintaining oral hygiene and health.

Fruit Enzymes, Imported Fungella Enzymes, Functional Probiotics, and Soda and Other Edible Grade Raw Materials: Targeting the food and beverage industry, these products underline Beijing Centergate Technologies' diversification. They serve as foundational ingredients for a variety of consumer goods, emphasizing the company's role within the food sector.

Investments in Software Technology, Communications and Electronic Engineering, Biomedicine, and Life Sciences: Apart from its tangible products, the company actively invests in several cutting-edge fields. These investments reflect its commitment to innovation and its strategic approach to capturing future growth opportunities in high-potential sectors.

Contact Information

Address: Pengrun Building, Beijing, China, 100016
Phone: 86 10 5776 8899